| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.
|
Nat Genet
|
2008
|
6.26
|
|
2
|
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
|
J Natl Cancer Inst
|
2010
|
4.54
|
|
3
|
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma.
|
J Natl Cancer Inst
|
2002
|
4.43
|
|
4
|
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.
|
Nat Genet
|
2010
|
4.20
|
|
5
|
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
|
JAMA
|
2007
|
3.62
|
|
6
|
Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study.
|
BMJ
|
2010
|
3.44
|
|
7
|
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.
|
Nat Genet
|
2010
|
3.37
|
|
8
|
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.
|
Nat Genet
|
2012
|
3.19
|
|
9
|
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|
Nat Genet
|
2011
|
3.07
|
|
10
|
Cell type-specific DNA methylation patterns in the human breast.
|
Proc Natl Acad Sci U S A
|
2008
|
2.99
|
|
11
|
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
|
Nat Genet
|
2005
|
2.92
|
|
12
|
Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer.
|
PLoS Genet
|
2011
|
2.47
|
|
13
|
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
|
Hum Mol Genet
|
2012
|
2.45
|
|
14
|
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma.
|
Gastroenterology
|
2003
|
2.39
|
|
15
|
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.
|
Clin Cancer Res
|
2004
|
2.17
|
|
16
|
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis.
|
Eur J Cancer
|
2005
|
2.16
|
|
17
|
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).
|
Lancet Oncol
|
2010
|
2.01
|
|
18
|
Risk factors for breast cancer: a reanalysis of two case-control studies from 1926 and 1931.
|
Epidemiology
|
2010
|
1.98
|
|
19
|
Incorporating genomics into breast and prostate cancer screening: assessing the implications.
|
Genet Med
|
2013
|
1.91
|
|
20
|
Public health implications from COGS and potential for risk stratification and screening.
|
Nat Genet
|
2013
|
1.79
|
|
21
|
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
|
Hum Mol Genet
|
2013
|
1.78
|
|
22
|
Genetic variation in the HSD17B1 gene and risk of prostate cancer.
|
PLoS Genet
|
2005
|
1.67
|
|
23
|
Common breast cancer susceptibility loci are associated with triple-negative breast cancer.
|
Cancer Res
|
2011
|
1.65
|
|
24
|
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
|
J Pathol
|
2004
|
1.59
|
|
25
|
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
|
Hum Mol Genet
|
2011
|
1.56
|
|
26
|
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals.
|
Gut
|
2012
|
1.52
|
|
27
|
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
|
Lancet
|
2003
|
1.52
|
|
28
|
Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
|
J Clin Oncol
|
2007
|
1.51
|
|
29
|
Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study.
|
Gynecol Oncol
|
2010
|
1.47
|
|
30
|
Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran.
|
PLoS One
|
2010
|
1.47
|
|
31
|
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies.
|
PLoS Med
|
2006
|
1.35
|
|
32
|
Role of genetic polymorphisms and ovarian cancer susceptibility.
|
Mol Oncol
|
2009
|
1.33
|
|
33
|
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.
|
J Clin Oncol
|
2012
|
1.29
|
|
34
|
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
|
Eur J Cancer
|
2006
|
1.24
|
|
35
|
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer.
|
Nat Commun
|
2012
|
1.23
|
|
36
|
Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays.
|
J Pathol
|
2005
|
1.19
|
|
37
|
Diabetes mellitus and its correlates in an Iranian adult population.
|
PLoS One
|
2011
|
1.19
|
|
38
|
Molecular pathology in epidemiologic studies: a primer on key considerations.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.14
|
|
39
|
Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.
|
J Pathol
|
2012
|
1.12
|
|
40
|
Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13.
|
Hum Mol Genet
|
2011
|
1.07
|
|
41
|
Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.
|
J Med Genet
|
2012
|
1.04
|
|
42
|
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
|
Cancer Epidemiol Biomarkers Prev
|
2014
|
1.03
|
|
43
|
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.02
|
|
44
|
Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers.
|
Int J Cancer
|
2004
|
1.01
|
|
45
|
Haplotypes of the estrogen receptor beta gene and breast cancer risk.
|
Int J Cancer
|
2008
|
0.99
|
|
46
|
Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.
|
Int J Cancer
|
2009
|
0.98
|
|
47
|
PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progression.
|
Int J Cancer
|
2011
|
0.98
|
|
48
|
9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.95
|
|
49
|
Translating genomics into improved population screening: hype or hope?
|
Hum Genet
|
2011
|
0.94
|
|
50
|
Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer.
|
Carcinogenesis
|
2005
|
0.93
|
|
51
|
Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.
|
BMC Med Genet
|
2011
|
0.90
|
|
52
|
Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.90
|
|
53
|
Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran.
|
Heart
|
2012
|
0.89
|
|
54
|
BRCA1 suppresses osteopontin-mediated breast cancer.
|
J Biol Chem
|
2006
|
0.89
|
|
55
|
What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
|
J Med Ethics
|
2013
|
0.85
|
|
56
|
Population-based screening in the era of genomics.
|
Per Med
|
2012
|
0.84
|
|
57
|
Reducing salt intake in Iran: priorities and challenges.
|
Arch Iran Med
|
2012
|
0.82
|
|
58
|
Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.
|
J Med Screen
|
2009
|
0.81
|
|
59
|
Polymorphisms in inflammation pathway genes and endometrial cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.81
|
|
60
|
Advocacy strategies and action plans for reducing salt intake in Iran.
|
Arch Iran Med
|
2012
|
0.80
|
|
61
|
HSD17B1 genetic variants and hormone receptor-defined breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.80
|
|
62
|
Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence.
|
Cancer Epidemiol
|
2010
|
0.78
|
|
63
|
How not to interpret a P value?
|
J Natl Cancer Inst
|
2007
|
0.78
|
|
64
|
Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults.
|
Hematology
|
2011
|
0.77
|
|
65
|
Association between KRAS rs61764370 and triple-negative breast cancer--a false positive?
|
Lancet Oncol
|
2011
|
0.76
|
|
66
|
Outside the Box: Proactive care: the patient's right to choose.
|
Br J Gen Pract
|
2013
|
0.75
|
|
67
|
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests.
|
Hered Cancer Clin Pract
|
2011
|
0.75
|
|
68
|
Any conclusion from this "citizens' jury" will be seriously flawed.
|
BMJ
|
2012
|
0.75
|
|
69
|
Catastrophic failures of public health.
|
Lancet
|
2004
|
0.75
|